Filing Details
- Accession Number:
- 0000930413-10-004647
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-27 16:41:45
- Reporting Period:
- 2010-08-26
- Filing Date:
- 2010-08-27
- Accepted Time:
- 2010-08-27 16:41:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
727510 | Enzon Pharmaceuticals Inc | ENZN | Biological Products, (No Disgnostic Substances) (2836) | 222372868 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1007931 | Robert Lebuhn | C/O Enzon Pharmaceuticals, Inc. 685 Route 202/206 Bridgewater, NJ 08807 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-08-26 | 4,600 | $10.50 | 111,919 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-08-26 | 400 | $10.51 | 111,519 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-08-26 | 5,000 | $10.49 | 106,519 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |